BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 14565284)

  • 1. 2-Phenylhydroxypropynyladenosine derivatives as high potent agonists at A2B adenosine receptor subtype.
    Lambertucci C; Volpini R; Costanzi S; Taffi S; Vittori S; Cristalli G
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):809-12. PubMed ID: 14565284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A2B adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyl adenosine and NECA derivatives.
    Vittori S; Costanzi S; Lambertucci C; Portino FR; Taffi S; Volpini R; Klotz KN; Cristalli G
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):471-81. PubMed ID: 15043167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands.
    Volpini R; Costanzi S; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2002 Jul; 45(15):3271-9. PubMed ID: 12109910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
    Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5'-N-substituted carboxamidoadenosines as agonists for adenosine receptors.
    de Zwart M; Kourounakis A; Kooijman H; Spek AL; Link R; von Frijtag Drabbe Künzel JK; IJzerman AP
    J Med Chem; 1999 Apr; 42(8):1384-92. PubMed ID: 10212124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]- 9H-purin-9-yl]-N-ethyl-beta-D-ribofuranuronamide derivatives as useful templates for the development of A2B adenosine receptor agonists.
    Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Romagnoli R; Carrion MD; Cara LC; Moorman AR; Varani K; Borea PA
    J Med Chem; 2007 Jan; 50(2):374-80. PubMed ID: 17228880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor.
    Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Saponaro G; Baraldi S; Romagnoli R; Moorman AR; Gessi S; Varani K; Borea PA
    Bioorg Med Chem; 2007 Apr; 15(7):2514-27. PubMed ID: 17306548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Romagnoli R; Preti D; Bovero A; Pineda de Las Infantas MJ; Moorman A; Varani K; Borea PA
    J Med Chem; 2004 Oct; 47(22):5535-40. PubMed ID: 15481989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
    Adachi H; Palaniappan KK; Ivanov AA; Bergman N; Gao ZG; Jacobson KA
    J Med Chem; 2007 Apr; 50(8):1810-27. PubMed ID: 17378544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.
    van Tilburg EW; von Frijtag Drabbe Künzel J; de Groote M; Vollinga RC; Lorenzen A; IJzerman AP
    J Med Chem; 1999 Apr; 42(8):1393-400. PubMed ID: 10212125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
    Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
    J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of di- and tri-substituted adenosine derivatives and their affinities at human adenosine receptor subtypes.
    Volpini R; Camaioni E; Costanzi S; Vittori S; Klotz KN; Cristalli G
    Nucleosides Nucleotides; 1999; 18(11-12):2511-20. PubMed ID: 10639752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-substituted C5'-modified adenosines as A1 adenosine receptor agonists.
    Ashton TD; Baker SP; Hutchinson SA; Scammells PJ
    Bioorg Med Chem; 2008 Feb; 16(4):1861-73. PubMed ID: 18042389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists.
    Hausler NE; Devine SM; McRobb FM; Warfe L; Pouton CW; Haynes JM; Bottle SE; White PJ; Scammells PJ
    J Med Chem; 2012 Apr; 55(7):3521-34. PubMed ID: 22432713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A3 receptor.
    Volpini R; Buccioni M; Dal Ben D; Lambertucci C; Lammi C; Marucci G; Ramadori AT; Klotz KN; Cristalli G
    J Med Chem; 2009 Dec; 52(23):7897-900. PubMed ID: 19839592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
    Beukers MW; Wanner MJ; Von Frijtag Drabbe Künzel JK; Klaasse EC; IJzerman AP; Koomen GJ
    J Med Chem; 2003 Apr; 46(8):1492-503. PubMed ID: 12672250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice.
    Franchetti P; Cappellacci L; Vita P; Petrelli R; Lavecchia A; Kachler S; Klotz KN; Marabese I; Luongo L; Maione S; Grifantini M
    J Med Chem; 2009 Apr; 52(8):2393-406. PubMed ID: 19317449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antagonistic interaction between A2B adenosine and D2 dopamine receptors modulates the function of rat carotid body chemoreceptor cells.
    Conde SV; Gonzalez C; Batuca JR; Monteiro EC; Obeso A
    J Neurochem; 2008 Dec; 107(5):1369-81. PubMed ID: 18823369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and adenosine receptor affinity and potency of 8-alkynyl derivatives of adenosine.
    Lambertucci C; Costanzi S; Vittori S; Volpini R; Cristalli G
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1153-7. PubMed ID: 11562976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.